Home › Roche Obtains CE Mark for Harmony Noninvasive Prenatal Test

Roche Obtains CE Mark for Harmony Noninvasive Prenatal Test

Sep 29, 2016

NEW YORK (GenomeWeb) – Roche said today that its Harmony Prenatal Test, a noninvasive prenatal test for fetal trisomy 21 and other chromosomal disorders that uses cell-free DNA from maternal blood, has received the CE mark.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Dec
12
Featured Webinar

Precision Metagenomics to Identify Patients at Risk for Invasive Infection

This webinar will discuss the use of shotgun metagenomics to identify children at risk of hospital-acquired infection.

What's Popular?

In Molecular Diagnostics

  1. Guardant Health to Launch Cell-Free DNA Assay for Cancer Recurrence Monitoring in 2019

    Premium

  2. Legislators Release New Draft Bill Incorporating FDA Ideas for Diagnostics Regulation

  3. SABCS 2018 Features Molecular Diagnostics Research

  4. Novacyt to Sell Cytology, Clinical Lab Units

  5. PredictImmune Gains CE-IVD Mark for IBD Test

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.